The TTC19 gene helps mitochondria, the parts of cells that make energy, keep one step of energy production working properly. If the gene does not work well, cells may struggle to make enough energy, especially in the brain and muscles, which can lead to movement problems, weakness, changes in speech or learning, or loss of skills in some people. Pathogenic variants in the TTC19 gene are linked to a rare inherited mitochondrial condition.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly direct when, where, and how strongly certain processes take place. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can find more in the LearnHub.
Overview
TTC19Gene function
What if the gene works
The TTC19 gene helps mitochondria, your cells’ energy centers, keep a key energy system called complex III working properly. This supports steady energy production, especially in tissues with high energy needs such as the brain and muscles.
Risk
What if the gene does not work
Variants in the TTC19 gene can reduce energy production in cells and may lead to a rare neurologic condition with movement problems, speech changes, and developmental decline. Effects range from milder later-onset problems to more severe early-onset disease.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the TTC19 gene is currently established for people with a pathogenic variant in this gene.
Conditions associated with TTC19
Gene function
What if the gene works
Your cells need a steady supply of energy, especially in the brain, muscles, and heart. The TTC19 gene helps mitochondria, the cell’s energy centers, keep one key step of energy production in mitochondria running smoothly. Its protein works in the inner membrane of mitochondria, where cells turn energy from food into usable power.
The TTC19 gene supports complex III, one link in the cell’s energy chain inside mitochondria. This helps electrons move along the chain so cells can make the energy they need for routine work.
Inside mitochondria, TTC19 helps clear older or extra pieces linked to complex III. This cleanup supports the normal upkeep of that energy making machinery.
By helping complex III stay functional, this gene supports the energy gradient that mitochondria use to make ATP (the cell’s main energy currency). That steady ATP supply helps tissues meet everyday demands.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TTC19 gene often make the protein shorter, unstable, or unable to interact normally with complex III in mitochondria, the cell’s energy centers. This explains how TTC19 gene variants affect mitochondria: milder variants may leave some activity, while more severe variants can lead to little or no working protein and a larger drop in cellular energy production. In TTC19-related mitochondrial disease, that difference can influence when symptoms start and how pronounced they are.
How variants are linked to conditions
Pathogenic variants in the TTC19 gene cause mitochondrial complex III deficiency, nuclear type 2, a rare inherited condition that most often affects the brain and muscles. In TTC19 gene and mitochondrial complex III deficiency, people may develop developmental delay, loss of skills, balance or movement problems, speech changes, or psychiatric symptoms, with symptoms starting in childhood or adulthood. Different variants can lead to different patterns and severity.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific outside factors that increase or reduce risk related to the TTC19 gene. For TTC19-related mitochondrial disease, risk is mainly shaped by the gene changes a person inherits, so family history is the main thing that can raise the chance in relatives.
Inheritance of TTC19 variants
TTC19-related conditions are inherited in an autosomal recessive pattern. This means a child must inherit two changed copies of the TTC19 gene, one from each parent, to have the condition. Parents who carry one TTC19 gene variant usually do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a child who is a carrier, and a 25% chance of resulting in a child who inherits neither variant.
What does my TTC19 result mean for my family?
For families, a TTC19 result usually matters most for brothers, sisters, and future children because TTC19-related conditions are typically passed down in a recessive pattern. Parents are often healthy carriers, and siblings may also be carriers or, less often, have the condition. Other relatives may want to learn whether the same gene change runs in the family, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
Doctors find variants in the TTC19 gene with genetic testing, usually by analyzing DNA from a blood sample or saliva sample. Testing for variants in the TTC19 gene may use a multigene panel, exome sequencing, or genome sequencing. A lab reads the DNA code and reports whether a variant was found, not found, or needs more interpretation.
When should I consider getting a genetic test?
Testing for the TTC19 gene may be considered when someone has signs of a rare inherited condition that affects the body’s energy production, especially with unexplained movement problems, loss of skills, muscle weakness, or brain changes seen on scans. It can also help when a close family member has a known TTC19 gene change.
A genetic result is only one part of your health story
A genetic finding can provide meaningful insight, but how much it explains depends on the condition and the type of variant identified. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have little effect in another, or cause more side effects, and this kind of difference is a common part of everyday medical care.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the TTC19 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects someone may have. General health concerns, medication questions, or new symptoms after starting treatment are best discussed with your doctor.